Paradoxical effect of sodium valproate that aggravates epilepsy of MELAS in a patient with A3243G mutation of the mitochondrial DNA

Paradoxical effect of sodium valproate that aggravates epilepsy of MELAS in a patient with A3243G mutation of the mitochondrial DNA

Bibliographic Details
Main Authors:	Chen Yi-Min, Lin Chih-Ming, Thajeb Peterus
Format:	Article
Language:	English
Published:	De Gruyter 2007-03-01
Series:	Open Medicine
Subjects:	acidosis epilepsy melas mitochondrial disease paradoxical effect sodium valproate
Online Access:	https://doi.org/10.2478/s11536-007-0007-5

Similar Items

Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells
by: Harrison J. Burgin, et al.
Published: (2020-03-01)

The m.3243A > G mutation load in hair follicles from different scalp regions of patients with MELAS
by: Yuan-yuan LU, et al.
Published: (2018-08-01)

MELAS and Kearns–Sayre overlap syndrome due to the mtDNA m. A3243G mutation and large-scale mtDNA deletions
by: Nian Yu, et al.
Published: (2016-09-01)

Pathophysiological and clinical consequences of the mitochondrial DNA 3243A→G mutation
by: Rusanen, H. (Harri)
Published: (2000)

Prognosis of symptomatic patients with the A3243G mutation of mitochondrial DNA
by: Chi-Hung Liu, et al.
Published: (2012-09-01)

Onset of MELAS due to the m.3243A>G mutation is early if the large phenotypic variability is considered
by: Josef Finsterer, et al.
Published: (2017-03-01)

MELAS: clinical features, muscle biopsy and molecular genetics MELAS: manifestações clínicas, biópsia muscular e estudo molecular
by: Paulo José Lorenzoni, et al.
Published: (2009-09-01)

Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd
by: Abolghasem Rahimdel, et al.
Published: (2016-11-01)

Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
by: Jamie Bellinge, et al.
Published: (2016-09-01)

Topiramate and Valproate Compared in Treatment of Juvenile Myoclonic Epilepsy
by: J Gordon Millichap
Published: (2007-08-01)

Quantification of gait in mitochondrial m.3243A > G patients: a validation study
by: Rob Ramakers, et al.
Published: (2017-05-01)

EXPERIENCE GENERIC VALPROATE IN ADULTS WITH FOCAL EPILEPSY (RESULTS THE OBSERVATIONS IN MOSCOW HEALTH FACILITY OUTPATIENT NETWORK)
by: I. Yu. Artemova, et al.
Published: (2016-05-01)

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
by: El Sabaa RM, et al.
Published: (2020-08-01)

Clinical Value of Magnetic Resonance Spectroscopy in the Initial Evaluation of Patients with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
by: Hyunjoo Lee, et al.
Published: (2021-07-01)

Formulation of carbamazepine and sodium valproate fixed dose combination for management of epilepsy
by: Seabi, Mmakgomo Eunice
Published: (2020)

Phenotypic heterogeneity of MELAS
by: Josef Finsterer, et al.
Published: (2017-03-01)

PHARMACO-ECONOMIC EVALUATION OF THE USE OF VALPROATES IN TABLET FORMS IN EPILEPSY THERAPY
by: P. A. Balunov
Published: (2017-05-01)

Encefalopatía mitocondrial, acidosis láctica y eventos parecidos al ictus en un adolescente
by: José Vargas Díaz, et al.

Adult-onset of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome with hypothyroidism and psychiatric disorders
by: Yu-Xing Ge, et al.
Published: (2017-03-01)

The Effect of Voluntary Exercise and Prenatal Exposure to Sodium Valproate on Learning, Memory, and Anxiety of Rats’ Offspring
by: Parisa Farzad, et al.
Published: (2020-01-01)

Experience with Low-Dose Sodium Valproate in Idiopathic Generalized Epilepsy Patients: A Long-Term Follow-Up Study on Selective Cohort from North India
by: Deepak Goel, et al.
Published: (2021-01-01)

EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION OF VALPROATES
by: P. N. Vlasov
Published: (2016-06-01)

Cardiovascular abnormalities in adult patients with the 3243A>G mutation in mitochondrial DNA
by: Majamaa-Voltti, K. (Kirsi)
Published: (2007)

Myopathy and peripheral neuropathy associated with the 3243A>G mutation in mitochondrial DNA
by: Kärppä, M. (Mikko)
Published: (2004)

The expanding phenotype of MELAS caused by the m.3291T>C mutation in the MT-TL1 gene
by: E. Keilland, et al.
Published: (2016-03-01)

MELAS syndrome mimicking somatoform disorder
by: Inczedy-Farkas Gabriella, et al.
Published: (2011-12-01)

Case studies of two families with MIDD and MELAS: heteroplasmy level in m.3243A>G mutation and the first report on m.3271T>C mutation in Colombia
by: Jorge Luis Granadillo De Luque, et al.
Published: (2016-01-01)

Use of valproates in women of childbearing age and pregnant women with epilepsy
by: P. N. Vlasov
Published: (2015-03-01)

Correlation of Serum Biomarkers and Magnetic Resonance Spectroscopy in Monitoring Disease Progression in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Due to mtDNA A3243G Mutation
by: Ha Neul Lee, et al.
Published: (2018-07-01)

EXPERIENCE OF PROLONGED VALPROATE USE IN ADULT PATIENTS WITH FOCAL FORMS OF EPILEPSY (RESULTS OF OBSERVATION HELD IN OUT-PATIENT CLINICS OF MOSCOW)
by: S. G. Burd, et al.
Published: (2016-09-01)

KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
by: Kang-Sik Seo, et al.
Published: (2018-07-01)

Valproate, Brain Atrophy and Reversible Dementia
by: J Gordon Millichap
Published: (1995-11-01)

Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
by: Jiaai Li, et al.
Published: (2021-06-01)

Neuroimaging pattern and pathophysiology of cerebellar stroke-like lesions in MELAS with m.3243A>G mutation: a case report
by: Munenori Oyama, et al.
Published: (2020-05-01)

Effect of sodium valproate retard tablet on the oxidative stress system and cognitive function in patients with epilepsy
by: Jian-Feng Chen, et al.
Published: (2017-06-01)

Clinical-economic analysis of valproate microsphere form in focal epilepsy in adults (real world evidences)
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Perbedaan Fungsi Tiroid pada Epilepsi yang Mendapat Pengobatan Asam Valproat dan Karbamazepin
by: Aniceto Cardoso Barreto, et al.
Published: (2016-11-01)

MELAS syndrome as a unusual cause of hypoparathyroidism: clinical case
by: Diliara Sh. Umiarova, et al.
Published: (2019-04-01)

Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients
by: Manuela Tondelli, et al.
Published: (2020-07-01)

Effects of lamotrigine + sodium valproate therapy on the nerve cell nutrition and apoptosis status as well as inflammatory response in patients with intractable epilepsy
by: Wen Tang, et al.
Published: (2018-01-01)